REDWOOD CITY, Calif.--(BUSINESS WIRE)--iSchemaView, the leader in cerebrovascular imaging analysis, today announced it has received final approval for the use of the RAPID platform in Canada. The ...

REDWOOD CITY, Calif.--(BUSINESS WIRE)--iSchemaView, the leader in cerebrovascular imaging analysis, today announced that the company has signed Diagnostic Imaging Australia (DIA) to be the exclusive ...

RapidAI detects 33% more MeVOs than Viz.ai, with new real-world data presented at ESOC highlighting superior accuracy and deeper clinical insights "CT Perfusion is a powerful tool, but its full value ...

Cerebrovasular imaging company iSchemaView has received the FDA nod for its latest product the RAPID CTA, a 3D imaging platform for computed tomogrpahy angiography (CTA). “Our goal is to provide ...